Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Conmed (CNMD) Cost of Revenue (2016 - 2026)

Conmed filings provide 17 years of Cost of Revenue readings, the most recent being $133.6 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 6.9% to $133.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $614.3 million, a 6.44% increase, with the full-year FY2025 number at $624.2 million, up 8.76% from a year prior.
  • Cost of Revenue hit $133.6 million in Q1 2026 for Conmed, down from $154.9 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $171.8 million in Q3 2025 to a low of $106.3 million in Q1 2022.
  • Median Cost of Revenue over the past 5 years was $140.3 million (2024), compared with a mean of $139.7 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 31.8% in 2023 and later decreased 6.9% in 2026.
  • Conmed's Cost of Revenue stood at $119.0 million in 2022, then grew by 21.73% to $144.9 million in 2023, then increased by 1.88% to $147.6 million in 2024, then rose by 4.95% to $154.9 million in 2025, then fell by 13.76% to $133.6 million in 2026.
  • The last three reported values for Cost of Revenue were $133.6 million (Q1 2026), $154.9 million (Q4 2025), and $171.8 million (Q3 2025) per Business Quant data.